erythromycin has been researched along with imperatorin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, J; Min, J; Yao, J; Yu, Z; Zhang, Q | 1 |
| Dutour, R; Poirier, D | 1 |
1 review(s) available for erythromycin and imperatorin
| Article | Year |
|---|---|
Inhibitors of cytochrome P450 (CYP) 1B1.
Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship | 2017 |
1 other study(ies) available for erythromycin and imperatorin
| Article | Year |
|---|---|
Novel enoyl-ACP reductase (FabI) potential inhibitors of Escherichia coli from Chinese medicine monomers.
Topics: Anti-Bacterial Agents; Binding Sites; Computer Simulation; Curcumin; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Escherichia coli; Escherichia coli Proteins; Fatty Acid Synthase, Type II; Luteolin; Medicine, Chinese Traditional | 2010 |